Learn about Natco Pharma Ltd. in Hyderabad, Telangana.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...

Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API) of ...

is Rs 726.8 Natco Pharma Ltd, incorporated in the year 1981, has its registered office in Natco House, Road No 2 Banjara Hills, Hyderabad, Telangana, 500033, 91-040-23547532, 91-040-23548243.

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With effect from the closure of business hours on 31st March, 2025, Mr.

In 1997, Natco Pharma inaugurated Natco Research Center (NRC) at Sanathnagar, Hyderabad. In 2003, Natco Pharma launched its Oncology division with introduction of flagship brand VEENAT (generic ...

The Hyderabad-based pharmaceutical company reported ... Nuvama, in its latest research note, said NATCO Pharma’s Q3 performance was an “all-round miss”, with gross margin at 82.6% but ...

Natco Pharma updates on Risdiplam launch in India, Delhi High Court denies Roche's injunction plea, pricing set at ₹15,900.

The Delhi High Court has rejected an interim injunction plea from Swiss pharma major F Hoffmann La Roche against Hyderabad-based Natco Pharma in a patent infringement dispute related to the former's ...

The Hyderabad-based drug firm along with Celgene ... crore towards special incentive to employees during the quarter. Natco Pharma will initially invest US$1 million for a 51 per cent stake ...

Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.

Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹746.85. The stock has experienced fluctuations today, with a low ...